Liquidia (LQDA) Return on Capital Employed (2021 - 2026)
Liquidia (LQDA) recorded quarterly Return on Capital Employed of 21.19% in Q1 2026, up 168.54% quarter-over-quarter from 30.91% in Q4 2025, and up 9717.0% on a YoY basis from 0.22% in Q1 2025.
Liquidia (LQDA) Return on Capital Employed (2021 - 2026) Analysis & Trends
Liquidia's Return on Capital Employed history runs 6 years deep, the most recent figure standing at 21.19% for Q1 2026.
- In Q1 2026, Return on Capital Employed rose 9717.0% year-over-year to 21.19%; the TTM figure through Mar 2026 stood at 21.19% (up 9717.0% YoY), while the FY2025 annual figure was 35.84%, up 5568.0% from the prior year.
- Return on Capital Employed was 21.19% for Q1 2026 at Liquidia, up from 30.91% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 21.19% in Q1 2026 to a low of 84.28% in Q2 2025.
- Historically, Return on Capital Employed has averaged 49.13% across 5 years, with a median of 51.16% in 2023.
- The sharpest annual moves came in 2023 and 2026: Return on Capital Employed sank 4434 bps in 2023, then soared 9717 bps in 2026.
- A 5-year view of Return on Capital Employed shows it stood at 31.76% in 2022, then plunged by 140 bps to 76.1% in 2023, then gained by 20 bps to 60.7% in 2024, then surged by 49 bps to 30.91% in 2025, then soared by 169 bps to 21.19% in 2026.
- The last three Return on Capital Employed figures came in at 21.19% (Q1 2026), 30.91% (Q4 2025), and 65.51% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 8.52% |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | 27.58% |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 21.43% |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 20.04% |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | 7.34% |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | 6.92% |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 14.85% |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | -1.92% |
| 10 | Liquidia | 5.74 Bn | 5.52 Bn | 121.79 Mn | 21.19% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.19% |
| Dec 31, 2025 | -30.91% |
| Sep 30, 2025 | -65.51% |
| Jun 30, 2025 | -84.28% |
| Mar 31, 2025 | -75.98% |
| Dec 31, 2024 | -60.70% |
| Sep 30, 2024 | -61.57% |
| Jun 30, 2024 | -59.70% |
| Mar 31, 2024 | -68.45% |
| Dec 31, 2023 | -76.10% |
| Sep 30, 2023 | -51.16% |
| Jun 30, 2023 | -44.80% |
| Mar 31, 2023 | -27.43% |
| Dec 31, 2022 | -31.76% |
| Sep 30, 2022 | -33.99% |
| Jun 30, 2022 | -38.26% |
| Mar 31, 2022 | -45.85% |
| Dec 31, 2021 | -37.68% |
| Sep 30, 2021 | -40.25% |
| Jun 30, 2021 | -51.52% |